Literature DB >> 18322406

The long-term effects of oophorectomy on cognitive and motor aging are age dependent.

Walter A Rocca1, Brandon R Grossardt, Demetrius M Maraganore.   

Abstract

BACKGROUND: The evidence for a neuroprotective effect of estrogen in women remains controversial.
OBJECTIVE: We studied the long-term risk of parkinsonism and of cognitive impairment or dementia in women who underwent oophorectomy before menopause.
METHODS: We conducted a historical cohort study among all women residing in Olmsted County, Minn., USA, who underwent unilateral or bilateral oophorectomy before the onset of menopause for a noncancer indication from 1950 through 1987. Each member of the oophorectomy cohort was matched by age to a referent woman from the same population who had not undergone oophorectomy. In total, we studied 1,252 women with unilateral oophorectomy, 1,075 women with bilateral oophorectomy, and 2,368 referent women. Women were followed for a median of 25-30 years. Parkinsonism was assessed using screening and examination, through a medical records-linkage system, and through death certificates. Cognitive status was assessed using a structured questionnaire via a direct or proxy telephone interview.
RESULTS: The risk of parkinsonism and of cognitive impairment or dementia increased following oophorectomy. In particular, we observed significant linear trends of increasing risk for either outcome with younger age at oophorectomy.
CONCLUSION: Our findings, combined with previous laboratory and epidemiologic findings, suggest that estrogen may have an age-dependent neuroprotective effect. 2008 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2008        PMID: 18322406      PMCID: PMC2768565          DOI: 10.1159/000113718

Source DB:  PubMed          Journal:  Neurodegener Dis        ISSN: 1660-2854            Impact factor:   2.977


  10 in total

1.  Neuroscience: it's all in the timing.

Authors:  Tom Siegfried
Journal:  Nature       Date:  2007-01-25       Impact factor: 49.962

Review 2.  Estrogen, menopause, and the aging brain: how basic neuroscience can inform hormone therapy in women.

Authors:  John H Morrison; Roberta D Brinton; Peter J Schmidt; Andrea C Gore
Journal:  J Neurosci       Date:  2006-10-11       Impact factor: 6.167

3.  Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study.

Authors:  Peter P Zandi; Michelle C Carlson; Brenda L Plassman; Kathleen A Welsh-Bohmer; Lawrence S Mayer; David C Steffens; John C S Breitner
Journal:  JAMA       Date:  2002-11-06       Impact factor: 56.272

4.  Survival patterns after oophorectomy in premenopausal women: a population-based cohort study.

Authors:  Walter A Rocca; Brandon R Grossardt; Mariza de Andrade; George D Malkasian; L Joseph Melton
Journal:  Lancet Oncol       Date:  2006-10       Impact factor: 41.316

5.  History of the Rochester Epidemiology Project.

Authors:  L J Melton
Journal:  Mayo Clin Proc       Date:  1996-03       Impact factor: 7.616

6.  Long-term treatment with estrogen and progesterone enhances acquisition of a spatial memory task by ovariectomized aged rats.

Authors:  R B Gibbs
Journal:  Neurobiol Aging       Date:  2000 Jan-Feb       Impact factor: 4.673

7.  Postmenopausal hormone therapy and Alzheimer's disease risk: interaction with age.

Authors:  V W Henderson; K S Benke; R C Green; L A Cupples; L A Farrer
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-01       Impact factor: 10.154

8.  Increased risk of parkinsonism in women who underwent oophorectomy before menopause.

Authors:  W A Rocca; J H Bower; D M Maraganore; J E Ahlskog; B R Grossardt; M de Andrade; L J Melton
Journal:  Neurology       Date:  2007-08-29       Impact factor: 9.910

9.  Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause.

Authors:  W A Rocca; J H Bower; D M Maraganore; J E Ahlskog; B R Grossardt; M de Andrade; L J Melton
Journal:  Neurology       Date:  2007-08-29       Impact factor: 9.910

10.  Bilateral oophorectomy trends in Olmsted County, Minnesota, 1950-1987.

Authors:  L J Melton; E J Bergstralh; G D Malkasian; W M O'Fallon
Journal:  Epidemiology       Date:  1991-03       Impact factor: 4.822

  10 in total
  28 in total

Review 1.  Minireview: translational animal models of human menopause: challenges and emerging opportunities.

Authors:  Roberta Diaz Brinton
Journal:  Endocrinology       Date:  2012-07-09       Impact factor: 4.736

2.  Reassessing hysterectomy.

Authors:  Elizabeth A Stewart; Lynne T Shuster; Walter A Rocca
Journal:  Minn Med       Date:  2012-03

Review 3.  Postmenopausal hormone therapy and cognition.

Authors:  Anna C McCarrey; Susan M Resnick
Journal:  Horm Behav       Date:  2015-04-30       Impact factor: 3.587

4.  Evidence-based medicine: an analysis of prophylactic bilateral oophorectomy at time of hysterectomy for benign conditions.

Authors:  C A Larson
Journal:  Curr Oncol       Date:  2011-01       Impact factor: 3.677

5.  Female Sex and Brain-Selective Estrogen Benefit α-Synuclein Tetramerization and the PD-like Motor Syndrome in 3K Transgenic Mice.

Authors:  Molly M Rajsombath; Alice Y Nam; Maria Ericsson; Silke Nuber
Journal:  J Neurosci       Date:  2019-08-12       Impact factor: 6.167

6.  Estrogen attenuates ischemic oxidative damage via an estrogen receptor alpha-mediated inhibition of NADPH oxidase activation.

Authors:  Quan-Guang Zhang; Limor Raz; Ruimin Wang; Dong Han; Liesl De Sevilla; Fang Yang; Ratna K Vadlamudi; Darrell W Brann
Journal:  J Neurosci       Date:  2009-11-04       Impact factor: 6.167

Review 7.  Oestrogen signalling and neuroprotection in cerebral ischaemia.

Authors:  D Brann; L Raz; R Wang; R Vadlamudi; Q Zhang
Journal:  J Neuroendocrinol       Date:  2012-01       Impact factor: 3.627

Review 8.  Oophorectomy, estrogen, and dementia: a 2014 update.

Authors:  Walter A Rocca; Brandon R Grossardt; Lynne T Shuster
Journal:  Mol Cell Endocrinol       Date:  2014-02-05       Impact factor: 4.102

9.  Prophylactic bilateral oophorectomy at time of hysterectomy for women at low risk: acog revises practice guidelines for ovarian cancer screening in low-risk women.

Authors:  C A Larson
Journal:  Curr Oncol       Date:  2014-02       Impact factor: 3.677

Review 10.  Can Exercise Ameliorate Aromatase Inhibitor-Induced Cognitive Decline in Breast Cancer Patients?

Authors:  Cuicui Li; Chenglin Zhou; Rena Li
Journal:  Mol Neurobiol       Date:  2015-07-30       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.